Role of the IL-6-JAK1-STAT3-Oct-4 pathway in the conversion of non-stem cancer cells into cancer stem-like cells
- 30 April 2013
- journal article
- Published by Elsevier BV in Cellular Signalling
- Vol. 25 (4), 961-969
- https://doi.org/10.1016/j.cellsig.2013.01.007
Abstract
No abstract availableKeywords
Funding Information
- NCI (CA140554, HL08336)
- DOD Breast Cancer Program (BC103217)
- World Class University (R31-2008-000-10103-0)
- P30CA047904
This publication has 69 references indexed in Scilit:
- Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretionProceedings of the National Academy of Sciences of the United States of America, 2011
- Migfilin Interacts with Src and Contributes to Cell-Matrix Adhesion-mediated Survival SignalingOnline Journal of Public Health Informatics, 2009
- Looking ahead in cancer stem cell researchNature Biotechnology, 2009
- ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical OutcomeCell Stem Cell, 2007
- Auranofin blocks interleukin‐6 signalling by inhibiting phosphorylation of JAK1 and STAT3Immunology, 2007
- Targeted therapy for cancer stem cells: the patched pathway and ABC transportersOncogene, 2007
- Beyond tumorigenesis: cancer stem cells in metastasisCell Research, 2006
- STAT3 is required but not sufficient for EGF receptor-mediated migration and invasion of human prostate carcinoma cell linesBritish Journal of Cancer, 2006
- Stem cell biology and the cellular pathways of carcinogenesisAPMIS, 2005
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences of the United States of America, 2003